{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T11:55:32Z","timestamp":1783338932510,"version":"3.54.6"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["476071\/2011-9"],"award-info":[{"award-number":["476071\/2011-9"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Minas Gerais","doi-asserted-by":"publisher","award":["PPM-00508-18"],"award-info":[{"award-number":["PPM-00508-18"]}],"id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflamm. Res."],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s00011-025-02146-w","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T12:17:19Z","timestamp":1764159439000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Angiotensin-(1-7) treatment improves pneumonia and prevents sepsis caused by pneumococcal infection"],"prefix":"10.1007","volume":"74","author":[{"given":"Eliza Mathias","family":"Melo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Izabela","family":"Galv\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franciel Batista","family":"Felix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda Medeiros Vale","family":"Magalh\u00e3es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavia","family":"Rago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina Gomes","family":"Machado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando Roque","family":"Ascen\u00e7\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Jos\u00e9","family":"Campagnole-Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robson Augusto Souza","family":"dos Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geovanni Dantas","family":"Cassali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro Martins","family":"Teixeira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,26]]},"reference":[{"key":"2146_CR1","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/490346","volume":"2013","author":"HC Steel","year":"2013","unstructured":"Steel HC, Cockeran R, Anderson R, Feldman C. Overview of community-acquired pneumonia and the role of inflammatory mechanisms in the immunopathogenesis of severe pneumococcal disease. Mediators Inflamm. 2013;2013:490346.","journal-title":"Mediators Inflamm"},{"key":"2146_CR2","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1165\/rcmb.2018-0021OC","volume":"60","author":"D Ahn","year":"2019","unstructured":"Ahn D, Wickersham M, Riquelme S, Prince A. The effects of IFN-lambda on epithelial barrier function contribute to Klebsiella pneumoniae ST258 pneumonia. Am J Respir Cell Mol Biol. 2019;60:158\u201366.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2146_CR3","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s10096-011-1272-4","volume":"31","author":"T Welte","year":"2012","unstructured":"Welte T. Risk factors and severity scores in hospitalized patients with community-acquired pneumonia: prediction of severity and mortality. Eur J Clin Microbiol Infect Dis. 2012;31:33\u201347.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2146_CR4","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1056\/NEJMcp2303286","volume":"389","author":"TM File Jr","year":"2023","unstructured":"File TM Jr, Ramirez JA. Community-acquired pneumonia. N Engl J Med. 2023;389:632\u201341.","journal-title":"N Engl J Med"},{"key":"2146_CR5","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.lab.2004.02.002","volume":"143","author":"C Feldman","year":"2004","unstructured":"Feldman C. Clinical relevance of antimicrobial resistance in the management of pneumococcal community-acquired pneumonia. J Lab Clin Med. 2004;143:269\u201383.","journal-title":"J Lab Clin Med"},{"key":"2146_CR6","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1471-2334-4-21","volume":"4","author":"P Martens","year":"2004","unstructured":"Martens P, Worm SW, Lundgren B, Konradsen HB, Benfield T. Serotype-specific mortality from invasive Streptococcus pneumoniae disease revisited. BMC Infect Dis. 2004;4:21.","journal-title":"BMC Infect Dis"},{"key":"2146_CR7","volume":"10","author":"JN Luck","year":"2020","unstructured":"Luck JN, Tettelin H, Orihuela CJ. Sugar-coated killer: serotype 3 pneumococcal disease. Front Cell Infect Microbiol. 2020;10:613287.","journal-title":"Front Cell Infect Microbiol"},{"key":"2146_CR8","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1128\/CVI.00591-15","volume":"23","author":"EH Choi","year":"2016","unstructured":"Choi EH, Zhang F, Lu YJ, Malley R. Capsular polysaccharide (CPS) release by serotype 3 pneumococcal strains reduces the protective effect of anti-type 3 CPS antibodies. Clin Vaccine Immunol. 2016;23:162\u20137.","journal-title":"Clin Vaccine Immunol"},{"key":"2146_CR9","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/s41579-024-01116-z","volume":"23","author":"AR Narciso","year":"2025","unstructured":"Narciso AR, Dookie R, Nannapaneni P, Normark S, Henriques-Normark B. Streptococcus pneumoniae epidemiology, pathogenesis and control. Nat Rev Microbiol. 2025;23:256\u201371.","journal-title":"Nat Rev Microbiol"},{"key":"2146_CR10","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1378\/chest.12-0210","volume":"142","author":"DH Dockrell","year":"2012","unstructured":"Dockrell DH, Whyte MKB, Mitchell TJ. Pneumococcal pneumonia: mechanisms of infection and resolution. Chest. 2012;142:482\u201391.","journal-title":"Chest"},{"key":"2146_CR11","doi-asserted-by":"publisher","DOI":"10.1128\/microbiolspec.GPP3-0004-2018","author":"AJ Loughran","year":"2019","unstructured":"Loughran AJ, Orihuela CJ, Tuomanen EI. Streptococcus pneumoniae: invasion and inflammation. Microbiol Spectr. 2019. https:\/\/doi.org\/10.1128\/microbiolspec.GPP3-0004-2018.","journal-title":"Microbiol Spectr"},{"key":"2146_CR12","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1146\/annurev-physiol-021113-170408","volume":"76","author":"BD Levy","year":"2014","unstructured":"Levy BD, Serhan CN. Resolution of acute inflammation in the lung. Annu Rev Physiol. 2014;76:467\u201392.","journal-title":"Annu Rev Physiol"},{"key":"2146_CR13","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.it.2019.01.007","volume":"40","author":"MA Sugimoto","year":"2019","unstructured":"Sugimoto MA, Vago JP, Perretti M, Teixeira MM. Mediators of the resolution of the inflammatory response. Trends Immunol. 2019;40:212\u201327.","journal-title":"Trends Immunol"},{"key":"2146_CR14","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1096\/fj.201601222R","volume":"31","author":"CN Serhan","year":"2017","unstructured":"Serhan CN. Treating inflammation and infection in the 21st century: new hints from decoding resolution mediators and mechanisms. FASEB J. 2017;31:1273\u201388.","journal-title":"FASEB J"},{"key":"2146_CR15","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1111\/bph.16323","volume":"181","author":"VV Costa","year":"2024","unstructured":"Costa VV, Resende F, Melo EM, Teixeira MM. Resolution pharmacology and the treatment of infectious diseases. Br J Pharmacol. 2024;181:917\u201337.","journal-title":"Br J Pharmacol"},{"key":"2146_CR16","volume":"7","author":"W Nie","year":"2012","unstructured":"Nie W, Zhang Y, Cheng J, Xiu Q. Corticosteroids in the treatment of community-acquired pneumonia in adults: a meta-analysis. PLoS ONE. 2012;7:e47926.","journal-title":"PLoS ONE"},{"key":"2146_CR17","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1096\/fj.201902172R","volume":"34","author":"MG Machado","year":"2020","unstructured":"Machado MG, Tavares LP, Souza GVS, Queiroz-Junior CM, Ascencao FR, Lopes ME, et al. The annexin A1\/FPR2 pathway controls the inflammatory response and bacterial dissemination in experimental pneumococcal pneumonia. FASEB J. 2020;34:2749\u201364.","journal-title":"FASEB J"},{"key":"2146_CR18","doi-asserted-by":"crossref","first-page":"3898","DOI":"10.1111\/bph.15164","volume":"177","author":"LP Sousa","year":"2020","unstructured":"Sousa LP, Pinho V, Teixeira MM. Harnessing inflammation resolving-based therapeutic agents to treat pulmonary viral infections: what can the future offer to COVID-19? Br J Pharmacol. 2020;177:3898\u2013904.","journal-title":"Br J Pharmacol"},{"key":"2146_CR19","doi-asserted-by":"crossref","unstructured":"Rago F, Melo EM, Miller LM, Duray AM, Felix FB, Vago JP, et al. Treatment with lipoxin A 4 improves influenza A infection outcome through macrophage reprogramming, anti-inflammatory and pro-resolutive responses. Res Sq. 2024.","DOI":"10.21203\/rs.3.rs-4491036\/v1"},{"key":"2146_CR20","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2022.101601","volume":"59","author":"LP Tavares","year":"2022","unstructured":"Tavares LP, Melo EM, Sousa LP, Teixeira MM. Pro-resolving therapies as potential adjunct treatment for infectious diseases: evidence from studies with annexin A1 and angiotensin-(1-7). Semin Immunol. 2022;59:101601.","journal-title":"Semin Immunol"},{"key":"2146_CR21","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1111\/bph.13057","volume":"172","author":"GS Magalhaes","year":"2015","unstructured":"Magalhaes GS, Rodrigues-Machado MG, Motta-Santos D, Silva AR, Caliari MV, Prata LO, et al. Angiotensin-(1-7) attenuates airway remodelling and hyperresponsiveness in a model of chronic allergic lung inflammation. Br J Pharmacol. 2015;172:2330\u201342.","journal-title":"Br J Pharmacol"},{"key":"2146_CR22","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1530\/JOE-12-0341","volume":"216","author":"RA Santos","year":"2013","unstructured":"Santos RA, Ferreira AJ, Verano-Braga T, Bader M. Angiotensin-converting enzyme 2, angiotensin-(1-7) and Mas: new players of the renin-angiotensin system. J Endocrinol. 2013;216:R1\u201317.","journal-title":"J Endocrinol"},{"key":"2146_CR23","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/808726","volume":"2012","author":"LC Barroso","year":"2012","unstructured":"Barroso LC, Silveira KD, Lima CX, Borges V, Bader M, Rachid M, et al. Renoprotective effects of AVE0991, a nonpeptide Mas receptor agonist, in experimental acute renal injury. Int J Hypertens. 2012;2012:808726. https:\/\/doi.org\/10.1155\/2012\/808726.","journal-title":"Int J Hypertens"},{"key":"2146_CR24","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.peptides.2013.05.012","volume":"46","author":"KD Silveira","year":"2013","unstructured":"Silveira KD, Coelho FM, Vieira AT, Barroso LC, Queiroz-Junior CM, Costa VV, et al. Mechanisms of the anti-inflammatory actions of the angiotensin type 1 receptor antagonist losartan in experimental models of arthritis. Peptides. 2013;46:53\u201363.","journal-title":"Peptides"},{"key":"2146_CR25","doi-asserted-by":"crossref","first-page":"5569","DOI":"10.4049\/jimmunol.1000314","volume":"185","author":"KD da Silveira","year":"2010","unstructured":"da Silveira KD, Coelho FM, Vieira AT, Sachs D, Barroso LC, Costa VV, et al. Anti-inflammatory effects of the activation of the angiotensin-(1-7) receptor, MAS, in experimental models of arthritis. J Immunol. 2010;185:5569\u201376.","journal-title":"J Immunol"},{"key":"2146_CR26","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/JLB.MA1218-490RR","volume":"106","author":"F Rago","year":"2019","unstructured":"Rago F, Melo EM, Kraemer L, Galvao I, Cassali GD, Santos RAS, et al. Effect of preventive or therapeutic treatment with angiotensin 1\u20137 in a model of bleomycin-induced lung fibrosis in mice. J Leukoc Biol. 2019;106:677\u201386.","journal-title":"J Leukoc Biol"},{"key":"2146_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13101614","author":"KL Collins","year":"2021","unstructured":"Collins KL, Younis US, Tanyaratsrisakul S, Polt R, Hay M, Mansour HM, et al. Angiotensin-(1-7) peptide hormone reduces inflammation and pathogen burden during Mycoplasma pneumoniae infection in mice. Pharmaceutics. 2021. https:\/\/doi.org\/10.3390\/pharmaceutics13101614.","journal-title":"Pharmaceutics"},{"key":"2146_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.105292","volume":"163","author":"EM Melo","year":"2021","unstructured":"Melo EM, Del Sarto J, Vago JP, Tavares LP, Rago F, Goncalves APF, et al. Relevance of angiotensin-(1-7) and its receptor Mas in pneumonia caused by influenza virus and post-influenza pneumococcal infection. Pharmacol Res. 2021;163:105292. https:\/\/doi.org\/10.1016\/j.phrs.2020.105292.","journal-title":"Pharmacol Res"},{"key":"2146_CR29","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.147819","author":"I Zaidan","year":"2022","unstructured":"Zaidan I, Tavares LP, Sugimoto MA, Lima KM, Negreiros-Lima GL, Teixeira LC, et al. Angiotensin-(1-7)\/MasR axis promotes migration of monocytes\/macrophages with a regulatory phenotype to perform phagocytosis and efferocytosis. JCI Insight. 2022. https:\/\/doi.org\/10.1172\/jci.insight.147819.","journal-title":"JCI Insight"},{"key":"2146_CR30","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.773261","volume":"13","author":"MG Machado","year":"2022","unstructured":"Machado MG, Patente TA, Rouille Y, Heumel S, Melo EM, Deruyter L, et al. Acetate improves the killing of Streptococcus pneumoniae by alveolar macrophages via NLRP3 inflammasome and glycolysis-HIF-1alpha axis. Front Immunol. 2022;13:773261.","journal-title":"Front Immunol"},{"key":"2146_CR31","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1128\/CMR.3.2.171","volume":"3","author":"KP Klugman","year":"1990","unstructured":"Klugman KP. Pneumococcal resistance to antibiotics. Clin Microbiol Rev. 1990;3:171\u201396.","journal-title":"Clin Microbiol Rev"},{"key":"2146_CR32","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315:801\u201310.","journal-title":"JAMA"},{"key":"2146_CR33","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3389\/fimmu.2018.00058","volume":"9","author":"GS Magalhaes","year":"2018","unstructured":"Magalhaes GS, Barroso LC, Reis AC, Rodrigues-Machado MG, Gregorio JF, Motta-Santos D, et al. Angiotensin-(1-7) promotes resolution of eosinophilic inflammation in an experimental model of asthma. Front Immunol. 2018;9:58.","journal-title":"Front Immunol"},{"key":"2146_CR34","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.3389\/fimmu.2017.01596","volume":"8","author":"LC Barroso","year":"2017","unstructured":"Barroso LC, Magalhaes GS, Galvao I, Reis AC, Souza DG, Sousa LP, et al. Angiotensin-(1-7) promotes resolution of neutrophilic inflammation in a model of antigen-induced arthritis in mice. Front Immunol. 2017;8:1596.","journal-title":"Front Immunol"},{"key":"2146_CR35","doi-asserted-by":"crossref","DOI":"10.1016\/j.imbio.2019.12.002","volume":"225","author":"AC Bastos","year":"2020","unstructured":"Bastos AC, Magalhaes GS, Gregorio JF, Matos NA, Motta-Santos D, Bezerra FS, et al. Oral formulation angiotensin-(1-7) therapy attenuates pulmonary and systemic damage in mice with emphysema induced by elastase. Immunobiology. 2020;225:151893.","journal-title":"Immunobiology"},{"key":"2146_CR36","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1165\/rcmb.2007-0364OC","volume":"40","author":"RC Russo","year":"2009","unstructured":"Russo RC, Guabiraba R, Garcia CC, Barcelos LS, Roffe E, Souza AL, et al. Role of the chemokine receptor CXCR2 in bleomycin-induced pulmonary inflammation and fibrosis. Am J Respir Cell Mol Biol. 2009;40:410\u201321.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2146_CR37","doi-asserted-by":"crossref","unstructured":"Marim FM, Silveira TN, Lima DS, Jr., Zamboni DS. A method for generation of bone marrow-derived macrophages from cryopreserved mouse bone marrow cells. PLoS One 2010; 5:e15263.","DOI":"10.1371\/journal.pone.0015263"},{"key":"2146_CR38","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25:402\u20138.","journal-title":"Methods"},{"key":"2146_CR39","volume":"6","author":"CC Garcia","year":"2010","unstructured":"Garcia CC, Russo RC, Guabiraba R, Fagundes CT, Polidoro RB, Tavares LP, et al. Platelet-activating factor receptor plays a role in lung injury and death caused by Influenza A in mice. PLoS Pathog. 2010;6:e1001171.","journal-title":"PLoS Pathog"},{"key":"2146_CR40","volume":"8","author":"C Liu","year":"2021","unstructured":"Liu C, Chu D, Kalantar-Zadeh K, George J, Young HA, Liu G. Cytokines: from clinical significance to quantification. Adv Sci (Weinh). 2021;8:e2004433.","journal-title":"Adv Sci (Weinh)"},{"key":"2146_CR41","first-page":"27","volume":"36","author":"BN Dao","year":"2023","unstructured":"Dao BN, Le HDT, Nguyen KX, Tran TV, Tran CT, Luong TC, et al. Relationship between serum TNF-\u03b1, IL-6, and IL-10 levels and disease severity, and changes in the cytokines after treatment in patients with bacterial community-acquired pneumonia. Pneumon. 2023;36:27.","journal-title":"Pneumon"},{"key":"2146_CR42","doi-asserted-by":"crossref","first-page":"836","DOI":"10.4049\/jimmunol.0901809","volume":"184","author":"H Seki","year":"2010","unstructured":"Seki H, Fukunaga K, Arita M, Arai H, Nakanishi H, Taguchi R, et al. The anti-inflammatory and proresolving mediator resolvin E1 protects mice from bacterial pneumonia and acute lung injury. J Immunol. 2010;184:836\u201343.","journal-title":"J Immunol"},{"key":"2146_CR43","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.02144-19","author":"J Periselneris","year":"2019","unstructured":"Periselneris J, Ercoli G, Pollard T, Chimalapati S, Camberlein E, Szylar G, et al. Relative contributions of extracellular and internalized bacteria to early macrophage proinflammatory responses to Streptococcus pneumoniae. MBio. 2019. https:\/\/doi.org\/10.1128\/mBio.02144-19.","journal-title":"MBio"},{"key":"2146_CR44","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.chom.2011.04.012","volume":"9","author":"TB Clarke","year":"2011","unstructured":"Clarke TB, Francella N, Huegel A, Weiser JN. Invasive bacterial pathogens exploit TLR-mediated downregulation of tight junction components to facilitate translocation across the epithelium. Cell Host Microbe. 2011;9:404\u201314.","journal-title":"Cell Host Microbe"},{"key":"2146_CR45","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1007\/s10753-022-01708-y","volume":"45","author":"NM Godbole","year":"2022","unstructured":"Godbole NM, Chowdhury AA, Chataut N, Awasthi S. Tight junctions, the epithelial barrier, and Toll-like receptor-4 during lung injury. Inflammation. 2022;45:2142\u201362.","journal-title":"Inflammation"},{"key":"2146_CR46","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14122619","author":"N Gao","year":"2022","unstructured":"Gao N, Rezaee F. Airway epithelial cell junctions as targets for pathogens and antimicrobial therapy. Pharmaceutics. 2022. https:\/\/doi.org\/10.3390\/pharmaceutics14122619.","journal-title":"Pharmaceutics"},{"key":"2146_CR47","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1097\/CCM.0000000000000509","volume":"42","author":"SL Weiss","year":"2014","unstructured":"Weiss SL, Fitzgerald JC, Balamuth F, Alpern ER, Lavelle J, Chilutti M, et al. Delayed antimicrobial therapy increases mortality and organ dysfunction duration in pediatric sepsis. Crit Care Med. 2014;42:2409\u201317.","journal-title":"Crit Care Med"},{"key":"2146_CR48","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1097\/01.CCM.0000217961.75225.E9","volume":"34","author":"A Kumar","year":"2006","unstructured":"Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med. 2006;34:1589\u201396.","journal-title":"Crit Care Med"},{"key":"2146_CR49","unstructured":"Organization WH. Vaccine-preventable diseases surveillance standards: Pneumococcus. Vol. 2025, 2018."},{"key":"2146_CR50","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/bph.12159","volume":"169","author":"AC Simoes e Silva","year":"2013","unstructured":"Simoes e Silva AC, Silveira KD, Ferreira AJ, Teixeira MM. ACE2, angiotensin-(1-7) and Mas receptor axis in inflammation and fibrosis. Br J Pharmacol. 2013;169:477\u201392.","journal-title":"Br J Pharmacol"},{"key":"2146_CR51","doi-asserted-by":"crossref","first-page":"2934","DOI":"10.1016\/j.celrep.2020.02.013","volume":"30","author":"V Sencio","year":"2020","unstructured":"Sencio V, Barthelemy A, Tavares LP, Machado MG, Soulard D, Cuinat C, et al. Gut dysbiosis during influenza contributes to pulmonary pneumococcal superinfection through altered short-chain fatty acid production. Cell Rep. 2020;30:2934\u201347.","journal-title":"Cell Rep"},{"key":"2146_CR52","doi-asserted-by":"publisher","DOI":"10.3390\/cells11030532","author":"JAM Souza","year":"2022","unstructured":"Souza JAM, Carvalho AFS, Grossi LC, Zaidan I, de Oliveira LC, Vago JP, et al. Glucocorticoid-induced leucine zipper alleviates lung inflammation and enhances bacterial clearance during pneumococcal pneumonia. Cells. 2022. https:\/\/doi.org\/10.3390\/cells11030532.","journal-title":"Cells"},{"key":"2146_CR53","doi-asserted-by":"crossref","unstructured":"P. Tavares L, Br\u00fcggemann TR, M. Rezende R, G. Machado M, Cagnina RE, Shay AE, et al. Cysteinyl maresins reprogram macrophages to protect mice from streptococcus pneumoniae after influenza A virus infection. mBio 2022; 13:e0126722.","DOI":"10.1128\/mbio.01267-22"},{"key":"2146_CR54","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1128\/JVI.01210-07","volume":"82","author":"H Fujisawa","year":"2008","unstructured":"Fujisawa H. Neutrophils play an essential role in cooperation with antibody in both protection against and recovery from pulmonary infection with influenza virus in mice. J Virol. 2008;82:2772\u201383.","journal-title":"J Virol"},{"key":"2146_CR55","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.3389\/fimmu.2017.01799","volume":"8","author":"LP Tavares","year":"2017","unstructured":"Tavares LP, Garcia CC, Machado MG, Queiroz-Junior CM, Barthelemy A, Trottein F, et al. CXCR1\/2 antagonism is protective during influenza and post-influenza pneumococcal infection. Front Immunol. 2017;8:1799.","journal-title":"Front Immunol"},{"key":"2146_CR56","doi-asserted-by":"crossref","first-page":"14933","DOI":"10.1128\/JVI.79.23.14933-14944.2005","volume":"79","author":"TM Tumpey","year":"2005","unstructured":"Tumpey TM, Garcia-Sastre A, Taubenberger JK, Palese P, Swayne DE, Pantin-Jackwood MJ, et al. Pathogenicity of influenza viruses with genes from the 1918 pandemic virus: functional roles of alveolar macrophages and neutrophils in limiting virus replication and mortality in mice. J Virol. 2005;79:14933\u201344.","journal-title":"J Virol"},{"key":"2146_CR57","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s00011-016-0996-0","volume":"66","author":"LP Tavares","year":"2017","unstructured":"Tavares LP, Teixeira MM, Garcia CC. The inflammatory response triggered by Influenza virus: a two edged sword. Inflamm Res. 2017;66:283\u2013302.","journal-title":"Inflamm Res"},{"key":"2146_CR58","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/S0002-9440(10)62471-6","volume":"166","author":"AS Damazo","year":"2005","unstructured":"Damazo AS, Yona S, D\u2019Acquisto F, Flower RJ, Oliani SM, Perretti M. Critical protective role for annexin 1 gene expression in the endotoxemic murine microcirculation. Am J Pathol. 2005;166:1607\u201317.","journal-title":"Am J Pathol"},{"key":"2146_CR59","doi-asserted-by":"crossref","first-page":"29","DOI":"10.4103\/0975-3583.59983","volume":"1","author":"G Yang","year":"2010","unstructured":"Yang G, Hamacher J, Gorshkov B, White R, Sridhar S, Verin A, et al. The dual role of TNF in pulmonary edema. J Cardiovasc Dis Res. 2010;1:29\u201336.","journal-title":"J Cardiovasc Dis Res"},{"key":"2146_CR60","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1164\/rccm.200410-1349OC","volume":"171","author":"LK Lundblad","year":"2005","unstructured":"Lundblad LK, Thompson-Figueroa J, Leclair T, Sullivan MJ, Poynter ME, Irvin CG, et al. Tumor necrosis factor-alpha overexpression in lung disease: a single cause behind a complex phenotype. Am J Respir Crit Care Med. 2005;171:1363\u201370.","journal-title":"Am J Respir Crit Care Med"},{"key":"2146_CR61","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1471-2466-12-6","volume":"12","author":"K Zobel","year":"2012","unstructured":"Zobel K, Martus P, Pletz MW, Ewig S, Prediger M, Welte T, et al. Interleukin 6, lipopolysaccharide-binding protein and interleukin 10 in the prediction of risk and etiologic patterns in patients with community-acquired pneumonia: results from the German competence network CAPNETZ. BMC Pulm Med. 2012;12:6.","journal-title":"BMC Pulm Med"},{"key":"2146_CR62","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1183\/09031936.00040710","volume":"37","author":"R Martinez","year":"2011","unstructured":"Martinez R, Menendez R, Reyes S, Polverino E, Cilloniz C, Martinez A, et al. Factors associated with inflammatory cytokine patterns in community-acquired pneumonia. Eur Respir J. 2011;37:393\u20139.","journal-title":"Eur Respir J"},{"key":"2146_CR63","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1001\/archinte.167.15.1655","volume":"167","author":"JA Kellum","year":"2007","unstructured":"Kellum JA, Kong L, Fink MP, Weissfeld LA, Yealy DM, Pinsky MR, et al. Understanding the inflammatory cytokine response in pneumonia and sepsis: results of the genetic and inflammatory markers of sepsis (GenIMS) study. Arch Intern Med. 2007;167:1655\u201363.","journal-title":"Arch Intern Med"},{"key":"2146_CR64","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.166044","author":"JP Vago","year":"2023","unstructured":"Vago JP, Zaidan I, Perucci LO, Brito LF, Teixeira LC, Silva CMS, et al. Plasmin and plasminogen prevent sepsis severity by reducing neutrophil extracellular traps and systemic inflammation. JCI Insight. 2023. https:\/\/doi.org\/10.1172\/jci.insight.166044.","journal-title":"JCI Insight"},{"key":"2146_CR65","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.3389\/fimmu.2019.02885","volume":"10","author":"M Soto","year":"2019","unstructured":"Soto M, Gaffney KJ, Rodgers KE. Improving the innate immune response in Diabetes by modifying the renin angiotensin system. Front Immunol. 2019;10:2885.","journal-title":"Front Immunol"},{"key":"2146_CR66","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s00424-016-1917-3","volume":"469","author":"OH Wittekindt","year":"2017","unstructured":"Wittekindt OH. Tight junctions in pulmonary epithelia during lung inflammation. Pflugers Arch. 2017;469:135\u201347.","journal-title":"Pflugers Arch"},{"key":"2146_CR67","unstructured":"Dion CF, Ashurst JV. Streptococcus pneumoniae. StatPearls. Treasure Island (FL), 2025."},{"key":"2146_CR68","doi-asserted-by":"crossref","first-page":"L1166","DOI":"10.1152\/ajplung.00182.2003","volume":"285","author":"CB Coyne","year":"2003","unstructured":"Coyne CB, Gambling TM, Boucher RC, Carson JL, Johnson LG. Role of claudin interactions in airway tight junctional permeability. Am J Physiol Lung Cell Mol Physiol. 2003;285:L1166\u201378.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"2146_CR69","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/1465-9921-12-70","volume":"12","author":"Y Soini","year":"2011","unstructured":"Soini Y. Claudins in lung diseases. Respir Res. 2011;12:70.","journal-title":"Respir Res"},{"key":"2146_CR70","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1152\/physrev.00019.2012","volume":"93","author":"D Gunzel","year":"2013","unstructured":"Gunzel D, Yu AS. Claudins and the modulation of tight junction permeability. Physiol Rev. 2013;93:525\u201369.","journal-title":"Physiol Rev"},{"key":"2146_CR71","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1159\/000350470","volume":"20","author":"SS Cohen","year":"2013","unstructured":"Cohen SS, Min M, Cummings EE, Chen X, Sadowska GB, Sharma S, et al. Effects of interleukin-6 on the expression of tight junction proteins in isolated cerebral microvessels from yearling and adult sheep. NeuroImmunoModulation. 2013;20:264\u201373.","journal-title":"NeuroImmunoModulation"},{"key":"2146_CR72","doi-asserted-by":"crossref","first-page":"31263","DOI":"10.1074\/jbc.M111.238147","volume":"286","author":"T Suzuki","year":"2011","unstructured":"Suzuki T, Yoshinaga N, Tanabe S. Interleukin-6 (IL-6) regulates claudin-2 expression and tight junction permeability in intestinal epithelium. J Biol Chem. 2011;286:31263\u201371.","journal-title":"J Biol Chem"},{"key":"2146_CR73","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00107-18","author":"JA Grousd","year":"2019","unstructured":"Grousd JA, Rich HE, Alcorn JF. Host-pathogen interactions in Gram-positive bacterial pneumonia. Clin Microbiol Rev. 2019. https:\/\/doi.org\/10.1128\/CMR.00107-18.","journal-title":"Clin Microbiol Rev"}],"container-title":["Inflammation Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-025-02146-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00011-025-02146-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-025-02146-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T16:53:22Z","timestamp":1767200002000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00011-025-02146-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,26]]},"references-count":73,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["2146"],"URL":"https:\/\/doi.org\/10.1007\/s00011-025-02146-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6812678\/v1","asserted-by":"object"}]},"ISSN":["1023-3830","1420-908X"],"issn-type":[{"value":"1023-3830","type":"print"},{"value":"1420-908X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,26]]},"assertion":[{"value":"3 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"171"}}